Global Menopause Market Driven by Personalized Digital Menopause Management and Emergence of Non-hormonal Therapies

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

Straits Research, a leading market research organization, announced the release of the report titled “Menopause Market Size and Outlook-Forecast till 2034. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to the report, the market is valued at USD 19.26 billion in 2026, which is expected to grow to USD 29.19 billion by 2034. The projected CAGR for this period is 5.34%
The menopause market is segmented based on treatment type, distribution channel, and region. Some of the insights provided in the report are highlighted below:

• The hormone therapy segment is expected to register a CAGR of 6.21% during the forecast period.
• North America is expected to lead the menopause market during the forecast period, owing to a higher treatment adoption rate and the presence of major pharmaceutical & biotech companies investing in menopause therapies.
• Strong adoption of telemedicine and online pharmacies expands access to care in remote areas.
• Brazil is expected to lead the Latin America menopause market due to expanding preventive women's health services and public awareness campaigns.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

The contents of the report are as follows:

By Treatment Type

• Dietary Supplements
  • Multivitamin Supplements
  • Phytoestrogen Supplement
  • Antioxidant Supplements
  • Other Supplements
• Hormone Therapies
  • Progestin-only Medicines
  • Estrogen-only Medicines
  • Other Therapies
  • DNA Polymerases
• Non-hormonal Therapies
  • Gabapentinoids
  • Serotonin-norepinephrine Reuptake Inhibitors (SNRI)
  • Selective Serotonin Reuptake Inhibitors (SSRI)
  • Other Non-hormonal Therapies

By Distribution Channel

• Hospital Pharmacies
• Drug Stores & Retail Pharmacies
• Other Distribution Channels

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa